ProGripTM Self-Gripping Polyester Mesh in Incisional Hernia Prevention
NCT ID: NCT03912662
Last Updated: 2025-12-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
32 participants
INTERVENTIONAL
2019-09-18
2022-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After midline laparotomy, the probability to develop an incisional hernia ranges from 10% to 50% depending on the complexity of the surgery and patient state of health.
As the clinical data needed for the study corresponds with those collected by Club Hernie registry, the clinical study will use the established registry database to collect performance and safety data on the prevention of incisional hernias within 24 months post operatively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence
NCT05424484
Prevention of Incisional Hernia by Mesh Augmentation After Midline Laparotomy for Aortic Aneurysm Treatment
NCT00757133
Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair
NCT00960011
Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair
NCT06762561
Comparison of Self-Fixating vs Non-Fixating Hernia Mesh
NCT02062775
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary Objective The secondary objective of this investigation is to confirm the safety of ProGrip™ Self-gripping Polyester Mesh through the occurrence of adverse device effects or procedure related adverse events following the use of ProGrip™ Self- gripping Polyester Mesh in subjects undergoing procedures with midline laparotomies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hernia prevention cohort
single arm safety study, no control arm
Mesh augmented reinforcement
Abdominal wall sutureline reinforcement with ProgripTM Self-Gripping Polyester Mesh
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mesh augmented reinforcement
Abdominal wall sutureline reinforcement with ProgripTM Self-Gripping Polyester Mesh
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject is ≥ 18 years of age at the time of consent.
3. Subject will be undergoing an elective midline laparotomy.
4. Subject may have a combination of low- and high-risk factors but cannot exceed a total of 5 risk factors or have more than 2 high-risk factors. Subject must have at least 2 low-risk factors if subject does not have any high-risk factors. High- and low-risk factors include:
1. High-Risk Factors (maximum of 2): i.BMI≥ 35; ii.Prior open abdominal surgery; iii.Daily active smoker or Chronic Obstructive Pulmonary disease (COPD) diagnosis; iv. Current or recent (within 1 year) cancer diagnosis or chemotherapy treatment; v.History of or current abdominal aorta aneurism or surgery for abdominal aortaaneurism
2. Low-Risk Factors (minimum of 2, if no high-risk factors): i.25 ≤ BMI \< 35; ii.Age \> 45; iii.Uncontrolled diabetes; iv.Malnutrition as defined by 10% weight loss within the last 3 months; v.Current immunosuppressive treatment; vi.Undergoing colorectal surgery
Exclusion Criteria
2. Subject for which the device is used outside the product IFU, including;
1. Pregnant women: Women who are known or suspected to be pregnant, or who are planning to become pregnant during the study follow-up period
2. Subject who has an infection within 30 days of enrollment or, at the time of the surgery, has any active, acute or chronic infection(s) that are uncontrolled and/or requiring treatment such as antibiotics
3. Subject whose surgical site is contaminated or dirty/infected intraoperatively, as assessed by the Investigator (Exclude Altemeier classification III-IV).
3. Subject who had received a mesh in a previous ventral hernia repair or has a ventral hernia.
4. Investigator determined that a planned future surgery would interfere with application of mesh reinforcement.
5. Subject has participated in an investigational drug or device research study within 30 days of enrollment.
6. Subject has a life expectancy of \<2 years.
7. Subject has an ASA Physical Status Classification System score \>3.
8. Subject has \>5 total risk factors or \>2 high-risk factors
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic - MITG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Bertrand, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nīmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Besançon
Besançon, , France
CHU de Bordeaux
Bordeaux, , France
CHU de Bordeaux - Hôpital Haut-Lévêque
Bordeaux, , France
CHU Lille
Lille, , France
HCL Louis Pradel
Lyon, , France
CHU de Nantes
Nantes, , France
CHU de Nîmes
Nîmes, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
CHU de Rennes - Hôpital Pontchaillou
Rennes, , France
CHU Hopitaux de Rouen
Rouen, , France
CHU Strasbourg - Nouvel Hôpital Civil
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDT17048POETRY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.